Literature DB >> 34635605

Back to the Basics of Liquid Chromatography-Mass Spectrometry.

Young Jin Kim1, Soo-Youn Lee2,3, Mina Hur4.   

Abstract

Entities:  

Keywords:  LC-MS/MS; Liquid chromatography-mass spectrometry; Method

Mesh:

Year:  2022        PMID: 34635605      PMCID: PMC8548245          DOI: 10.3343/alm.2022.42.2.119

Source DB:  PubMed          Journal:  Ann Lab Med        ISSN: 2234-3806            Impact factor:   3.464


× No keyword cloud information.
Liquid chromatography-mass spectrometry (LC-MS/MS) is widely used in research and clinical areas, and its application is gradually increasing. The main uses of LC-MS/MS in clinical testing include screening newborns, therapeutic drug monitoring, and identifying drugs of abuse and metabolites and hormones [1]. New testing techniques using LC-MS/MS are continuously being researched and developed [2, 3]. Efforts are also being made for standardizing and harmonizing these techniques in clinical laboratories [4]. In practice, reproducing results of mass spectrometric analyses by referring to one or two method development research articles is challenging, mainly because researchers lack background knowledge, and articles often do not include detailed and necessary background knowledge. In this issue, the review article by Rappold [5], written from the author’s experience and other literature, will be of great help to researchers working on LC-MS/MS method development. This review article enlists the necessary elements for LC-MS/MS method development, which will aid researchers develop their own methods. Commercialization of the LC-MS/MS analytical kits for clinical research is in progress, and sophisticated LC-MS/MS equipment can be accessed by fully automating sample pretreatment [6]. However, even for commercialized kits, most pretreatment and analytical conditions must be verified in each laboratory. Since a newly developed method for a novel target is used in its original form, as developed in the laboratory, it is necessary to have the ability to develop the analytical method independently. Such measures will also help solve in-processing problems that may occur in the development and validation of MS methods. Currently, LC-MS/MS method development is highly dependent on the researcher’s experience and is therefore not standardized. To that end, Rappold has provided a valuable and complete account of all aspects of LC-MS/MS method development, including reagent selection, sample preparation, LC and MS conditions, calibration, quality control, and optimization. This review article by Rappold [5] is replete with helpful and practical information for researchers, technicians, and laboratory physicians working with LC-MS/MS.
  6 in total

1.  Evaluation of the first immunosuppressive drug assay available on a fully automated LC-MS/MS-based clinical analyzer suggests a new era in laboratory medicine.

Authors:  Sebastian Hörber; Andreas Peter; Rainer Lehmann; Miriam Hoene
Journal:  Clin Chem Lab Med       Date:  2020-10-19       Impact factor: 8.490

2.  Use of Liquid Chromatography-Tandem Mass Spectrometry for Clinical Testing in Korean Laboratories: a Questionnaire Survey.

Authors:  Hyojin Chae; Sung Eun Cho; Hyung Doo Park; Sail Chun; Yong Wha Lee; Yeo Min Yun; Sang Hoon Song; Sang Guk Lee; Kyunghoon Lee; Junghan Song; Soo Youn Lee
Journal:  Ann Lab Med       Date:  2019-09       Impact factor: 3.464

3.  Dried Blood Spot Multiplexed Steroid Profiling Using Liquid Chromatography Tandem Mass Spectrometry in Korean Neonates.

Authors:  Rihwa Choi; Hyung Doo Park; Hyeon Ju Oh; Kyounghoon Lee; Junghan Song; Soo Youn Lee
Journal:  Ann Lab Med       Date:  2019-05       Impact factor: 3.464

4.  A Sensitive and Specific Liquid Chromatography-Tandem Mass Spectrometry Assay for Simultaneous Quantification of Salivary Melatonin and Cortisol: Development and Comparison With Immunoassays.

Authors:  Sunghwan Shin; Hyeonju Oh; Hea Ree Park; Eun Yeon Joo; Soo-Youn Lee
Journal:  Ann Lab Med       Date:  2020-08-25       Impact factor: 3.464

5.  Immunosuppressive Drug Measurement by Liquid Chromatography Coupled to Tandem Mass Spectrometry: Interlaboratory Comparison in the Korean Clinical Laboratories.

Authors:  Hyun-Ki Kim; Hyung-Doo Park; Sang-Guk Lee; Hyojin Chae; Sang Hoon Song; Yong-Wha Lee; Yeo-Min Yun; Sunhyun Ahn; Serim Kim; Sun Min Lee; Soo-Youn Lee; Sail Chun
Journal:  Ann Lab Med       Date:  2021-05-01       Impact factor: 3.464

Review 6.  Review of the Use of Liquid Chromatography-Tandem Mass Spectrometry in Clinical Laboratories: Part I-Development.

Authors:  Brian A Rappold
Journal:  Ann Lab Med       Date:  2022-03-01       Impact factor: 3.464

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.